Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F01929)

Formulation Name

Atomoxetine 18 mg capsule

Company

Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Atomoxetine	DM5L6HI	Attention deficit hyperactivity disorder	6A05.Z	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	E00007	222	Alkalizing agent
Ferrosoferric oxide	E00231	14789	Colorant
Potassium hydroxide	E00233	14797	Alkalizing agent
Propylene glycol	E00040	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Quinoline yellow WS	E00309	24671	Colorant
Sodium lauryl sulfate	E00464	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------